1-4 of 4
Joseph Park
Close
Sort by
Journal Articles

The Impact of Degree of Anticoagulation on Thrombotic and Other Complications in Hospitalized COVID-19 Patients

Rena Zheng, Alexandra Solomon, Madeline DiLorenzo, Iniya Rajendran, Joseph Park, Vrushali Dhongade, Michael Garcia, Allan Walkey, Robert Eberhardt, John Mark Sloan, Janice Weinberg, Elizabeth S Klings
Journal: Blood
Blood (2021) 138 (Supplement 1): 1051.
https://doi.org/10.1182/blood-2021-148775
Published: 2021
Journal Articles

Extrapolation and Justification of Nplate Dosing to Improve Overall Survival in Acute Radiation Syndrome

Sameer Doshi, Zachary Jones, Ari Pritchard-Bell, Joseph Park, Per Olsson Gisleskog
Journal: Blood
Blood (2020) 136 (Supplement 1): 15–16.
https://doi.org/10.1182/blood-2020-139177
Published: 2020
Journal Articles

Assessment of Romiplostim Immunogenicity in Adult Patients in Clinical Trials and in a Global Registry

Troy E. Barger, BSc, Andy Boshier, MBChB, MSc, Vibha Jawa, PhD, June Kim, PhD, Daniel T. Mytych, PhD, Joseph Park, MD PhD, David J. Kuter, MD DPhil
Journal: Blood
Blood (2018) 132 (Supplement 1): 2427.
https://doi.org/10.1182/blood-2018-99-113484
Published: 2018
Journal Articles

A Single-Arm, Open-Label, Long-Term Efficacy and Safety Study of Subcutaneous (SC) Romiplostim in Children with Immune Thrombocytopenia (ITP)

John D. Grainger, MD MRCP, FRPATH, James B. Bussel, MD, Michael Tarantino, Nicola Cooper, MA, MD MRCP, FRCPath, Donald Beam, Jenny M. Despotovic, DO, MS, Alexey Maschan, MD PhD Professor, Nancy Carpenter, Melissa Eisen, Joseph Park
Journal: Blood
Blood (2017) 130 (Supplement 1): 2334.
https://doi.org/10.1182/blood.V130.Suppl_1.2334.2334
Published: 2017